Stock Ratings | Lake Street initiated coverage of NeoVolta (NEOV) with a buy rating and a price target of $11, representing a potential upside of 431.4%.
Tango Therapeutics, Inc. TNGX | 0.00 | |
ON Semiconductor Corporation ON | 0.00 | |
NeoVolta Inc NEOV | 0.00 | |
Omeros Corporation OMER | 0.00 | |
BlackRock, Inc. BLK | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
Jefferies: Upgrades Tango Therapeutics ( Tango Therapeutics, Inc.(TNGX.US) ) stock to "buy", raising its price target from $27 to $60.
Susquehanna: Maintaining a "positive" rating on ON Semiconductor ( ON Semiconductor Corporation(ON.US) ), while raising the price target from $120 to $140.
Evercore ISI Group: Maintaining its "Outperform Market" rating for ON Semiconductor ( ON Semiconductor Corporation(ON.US) ), while raising its price target from $121 to $137.
Lake Street: Initial rating for NeoVolta ( NeoVolta Inc(NEOV.US) ) stock at "Buy", with a target price of $11.
HC Wainwright & Co.: Maintaining a "buy" rating on Omeros Corporation ( Omeros Corporation(OMER.US) ), while lowering the price target from $40 to $33.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| Tango Therapeutics, Inc.(TNGX.US) | to lift | $60.0 | $31.47 | 90.66% | Jefferies |
| ON Semiconductor Corporation(ON.US) | to lift | $140.0 | $90.65 | 54.44% | Susquehanna |
| ON Semiconductor Corporation(ON.US) | to lift | $137.0 | $90.65 | 51.13% | Evercore ISI Group |
| ON Semiconductor Corporation(ON.US) | to lift | $135.0 | $90.65 | 48.92% | B. Riley Securities |
| BlackRock, Inc.(BLK.US) | to lift | $1430.0 | $964.71 | 48.23% | Morgan Stanley |
| NeoVolta Inc(NEOV.US) | Initial classification | $11.0 | $2.07 | 431.4% | Lake Street |
| Omeros Corporation(OMER.US) | cut | $33.0 | $8.67 | 280.62% | HC Wainwright & Co. |
| ProQR Therapeutics N.V.(PRQR.US) | cut | $3.0 | $1.53 | 96.08% | Chardan Capital |
| Figma(FIG.US) | cut | $36.0 | $18.62 | 93.34% | Wells Fargo |
| AeroVironment, Inc.(AVAV.US) | cut | $248.0 | $137.95 | 79.78% | Piper Sandler |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Jefferies: Maintaining a "buy" rating on Applied Materials Applied Materials, Inc.(AMAT.US) ) stock, while raising the price target from $510 to $770.
Needham: Upgrades Barnes & Noble Education ( Barnes & Noble Education, Inc.(BNED.US) ) stock to "buy", with a target price of $16.
Piper Sandler: Maintaining Flagstar Bank's ( Flagstar Financial(FLG.US) ) rating at "overweight", while raising the price target from $16.5 to $17.5.
First Coverage
Goldman Sachs: Initial rating for Crown Castle Crown Castle Inc.(CCI.US) ) stock at "neutral", with a target price of $95.
Needham: Initial rating for Nu Holdings ( Nu Holdings(NU.US) ) stock at "buy", with a target price of $17.
TD Securities: Initial rating for Constellation Brands ( Constellation Brands, Inc. Class A(STZ.US) ) stock at "Buy", with a target price of $174.
reduction
Piper Sandler: Maintaining AeroVironment's ( AeroVironment, Inc.(AVAV.US) ) rating at "overweight," while lowering the price target from $290 to $248.
Oppenheimer: Maintaining Nike's ( NIKE, Inc. Class B(NKE.US) ) rating at "Outperform Market," while lowering the price target from $120 to $60
Stephens & Co.: Downgraded Bio-Techne ( Bio-Techne Corporation(TECH.US) ) to "market-weighted" while raising its price target from $68 to $73.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.